(Q39397606)

English

Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Fred Sheftell

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Robert Ryan

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Verne Pitman

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Eletriptan Steering Committee

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

202-213

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Within-patient consistency of response of rizatriptan for treating migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03043.X

21 January 2018

Identifiers

10.1046/J.1526-4610.2003.03043.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

release_4un6zmtvbrdkbatnrbwflfrcsi

1 reference

https://api.fatcat.wiki/v0/release/4un6zmtvbrdkbatnrbwflfrcsi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39397606&oldid=1838780118"